← Leaderboards
Lidija Klampfer
Protexase Therapeutics, Inc.
$299,976
Attributed
$599,952
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $300K · FY2018–19$500K$375K$250K$125K$0
'18
'19
Funding mix
By agency
NIH$599,952 · 2
By mechanism
R43$599,952 · 2
Top collaborators
- James W Janetka2 shared
Others in their field
Other Emerging Leaders on “Fibroblasts”
- Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor$6,921,511
- Leonard Freedman · Leidos Biomedical Research, Inc.$5,982,481
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$4,861,794
- Kaifu Chen · Methodist Hospital Research Institute$4,859,015
- Giovanni Ligresti · Mayo Clinic Rochester$4,830,216
- Brian Prindle$4,494,879
Research focus
FibroblastsImproved OutcomeDrug KineticsFibrinogenHepatocyte Growth Factor ActivatorHgf GeneCombined Modality TherapyDrug DiscoveryEpidermal Growth Factor ReceptorEvaluationGrowthCancer CellBaseHepsinBenzamidinesColon CarcinomaAnticancer ActivityCancer TherapyBiologicalDrug TargetingCessation Of LifeEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorAnimal ModelInhibitor/Antagonist